| Item | Content |
|---|---|
| Rating | Neutral |
| Target price | RMB 180–198 (base case fair value, exit multiple 45x × FY2027E EPS 4.0–4.4) |
| Current price | RMB 204.95 (closing price, 2026-08-31) |
| Margin of safety | -12% (base fair value floor RMB 180 vs current price) |
| Probability-weighted expected value | RMB 186.8, -8.9% vs current price |
| Time horizon | 12 months |
| Prior conclusion (2026-08-11) | Neutral / Target price RMB 185–200 / Current price RMB 206.7 |
Montage Technology is the undisputed global leader in memory interface chips (36.8% share in 2024, ranked No.1; top-3 oligopoly CR3 of 93.4%). AI server volume ramp and DDR5 sub-generation iterations continue to drive fundamental delivery: 2026H1 revenue of RMB 3.335 billion (+26.7%), non-GAAP (recurring-adjusted) net profit of RMB 1.322 billion (+21.2%), interconnect gross margin of 69.3%. However, at the current price of RMB 204.95, the base case is essentially priced in — roughly 8.4% above the base fair value midpoint of RMB 189, with the probability-weighted expected value about 8.9% below the current price, implying asymmetrical odds skewed to the downside. The Korean criminal antitrust investigation (compounded by a US civil treble-damages inquiry on the same matter) constitutes an underpriced tail risk. Separating quality from price: a great company at a not-cheap price. We maintain Neutral and recommend waiting for a pullback to the lower end of the base range (around RMB 180) or clarity on the Korean investigation before building positions.
| Item | Prior (2026-08-11) | Current (2026-08-31) | Driver of Change |
|---|---|---|---|
| Rating | Neutral | Neutral (maintained) | H1 results delivered as pre-announced; no escalation in Korean investigation, but valuation conclusion unchanged |
| Target price range | RMB 185–200 | RMB 180–198 | TTM non-GAAP updated to RMB 2.253 billion; share count diluted to 1.2205 billion shares after H-share fundraising; minor adjustment to normalized base |
| judgment | fair | fair (maintained) | Deviation between current price and fair value essentially unchanged (+8.4%) |
| confidence | 0.50 | 0.55 | H1 report validates non-GAAP basis; PCIe 6.x Retimer passed PCI-SIG certification; buyback execution accelerated |
Key incremental facts: ① The 2026 interim report was disclosed on 8-29, with non-GAAP profit +21.2% at the midpoint of the pre-announced range and Q2 revenue +32.8% accelerating sequentially; ② PCIe 6.x/CXL 3.x Retimer passed PCI-SIG certification (8-24); CXL 3.2 MXC started trial production first and was adopted into Samsung/SK hynix products; ③ No new developments (indictment/prosecution/settlement) in the Korean investigation during August, but red-team verification found US law firms (Paul LLP, CPM) have launched civil treble-damages investigations into alleged DDR5 RCD price fixing, and MLex reported the US DOJ has been investigating the same case since January (California search warrant on January 13) — the tail risk has broadened geographically; ④ Buyback program of RMB 300–600 million is over half executed (approx. RMB 170–190 million as of 8-28) plus an interim dividend of RMB 242 million; ⑤ The stock stabilized around RMB 205 after a ~35% pullback from its early-July high of RMB 332.5.
Future changes: Three substantive changes occurred during this review period. First, the earnings pricing anchor faces a switch — in 2026H1 net profit +72.3% growth, non-recurring gains accounted for 33.8% (RMB 456 million from XConn/Marvell disposals, non-repeatable in H2); the market's pricing anchor will shift from reported net profit to the non-GAAP basis, with the Q3 report in late October as the first validation point. Second, the window for new products moving from "0→1" to "1→10" is opening — MRCD/MDB Gen 2 in volume trial, PCIe 6.x Retimer certified, and CXL 3.2 MXC in trial production adopted by both major DRAM makers — though the realization pace depends heavily on new-generation CPU platform timing. Third, the Korean investigation has entered a results-sensitive period — similar Korean cases typically conclude within 6–18 months; combined with the US civil claims track, the probability of an indictment/settlement/surcharge notice within the next 6–18 months is not low.
Primary share price drivers: ① Non-GAAP earnings quality (full-year non-GAAP growth ≥20% with OCF/non-GAAP around 1.0 → discount recovery; <15% → downgrade to bear case); ② New product ramp slope (new product revenue growth falling below 40% or interconnect gross margin below 65% → growth option falsified); ③ Korean investigation outcome (the only thesis breaker, directly hitting the pricing-power foundation behind the 69.3% gross margin).
Verifiable expectation gaps: Current price of RMB 204.95 = 51.2x FY2027E consensus EPS (TUSHARE RMB 4.0); back-solving at a 45x exit multiple implies 2027E EPS of 4.55, about 14% above consensus. Sell-side median target prices of RMB 363–387 (implying 90x+ 2027E multiples) are systematically far above the current price; this report does not adopt them — the disagreement lies in the exit multiple anchor: we anchor on Rambus's current TTM of 38.8x (calculated as of 2026-08-28) plus a 15–25% premium for Montage's share/product-category leadership to derive 45x; the sell-side implied 90x+ lacks precedent support. Market expectations are "reasonable to slightly high": the base case is essentially priced in; upside surprise potential lies in the bull case (earlier MRDIMM ramp + PCIe 6.x volume), while the Korean investigation tail is underpriced — odds are asymmetrical and skewed to the downside.
Validation catalysts and falsification conditions: See the tracking section at the end. Opportunity assessment conclusion: evidence grade B, industry tailwinds; dimension scores — change 3 / drivers 3 / expectation gap 2 / catalysts 3.
Key evidence
Two clarifications on definitions: First, Montage's highest mass-production speed today is the Gen 4 RCD04 (7200MT/s); 9200MT/s is in the sampling stage, so the claim that "competitors lead in mass production" does not hold — the real gap is a ~7-month difference in sampling timing. Second, the decline in overall gross margin to ~61.8% in 2026Q2 (Q1: 69.8%) was mainly due to the ramp of low-margin Jintide products (~RMB 178 million in Q2, gross margin only ~9.7%) plus a seasonal dip in interconnect gross margin (71.5%→67.4%, still +3.2pct YoY), not competitive deterioration — the impact of intensified competition on gross margin had not yet shown up in Q2 data. The essence of the moat is JEDEC standard-setting power (leading the DDR6 interface standard) plus pre-validation lock-in with CPU platforms and DRAM makers; no new entrant in over 20 years.
Key evidence
Quarterly weakening signals must be acknowledged: Q2 new product revenue was ~RMB 269 million, flat vs Q1 (zero sequential growth), with its share of interconnect revenue falling from 19.0% in Q1 to ~15.9%, and YoY growth decelerating from +93.8% in Q1 to ~+69% — the slope evidence for "second curve taking shape" was unfavorable in the latest quarter. Additionally, the PCIe Retimer faces Astera Labs' first-mover pressure (FY2025 revenue of US$852.5 million, +115%); CXL MXC is currently in "trial production/adoption" rather than volume orders; the MRCD/MDB realization window is 2027–2029 and highly dependent on the launch timing of new-generation server CPU platforms (memory channels 8/12→16). The second curve's direction is clear and positioning is leading (both MRCD/MDB and CKD were global firsts), but its contribution to the P&L within 2026 remains limited.
Key evidence
Two clarifications to avoid exaggeration: First, the consecutive decline in OCF/attributable net profit (1.62→1.20→0.90→0.66) is largely a false signal mechanically caused by one-off gains inflating the denominator — 2026H1 OCF of RMB 1.328 billion / non-GAAP of RMB 1.322 billion ≈ 1.00, meaning cash conversion relative to non-GAAP profit is ~100%, and OCF grew +25.4% YoY; cash generation has not deteriorated. Second, the largest customer accounting for 48.7% of accounts receivable is broadly in line with 48.62% at end-2025 — an existing structure, not new risk (counterparties are Samsung/hynix-grade credits; no historical bad debts). The real core issue: from H2, the one-off gain base disappears; if the market continues extrapolating on the reported net profit basis, the +72.3% headline growth will converge toward the low-20s% non-GAAP growth, creating selling pressure from expectation gap snapback at high valuations; accounts receivable +71.7% far exceeding revenue +26.7% (receivables/half-year revenue ratio rising from ~21.6% to 29.2%) needs monitoring as to whether it is a timing effect of record Q2 revenue.
Key evidence
Mechanistically, two independent legal tracks must be distinguished: treble civil damages are private litigation under the US Clayton Act, separate from the Korean criminal proceedings; Montage is a Chinese company, and the pathway by which US civil claims could reach it has not been established. The market bear view holds investigation risk is manageable — CLSA stated publicly on 2026-07-20 that "the risk of South Korean price-manipulation charges is relatively low and the valuation is attractive"; moreover, the single-day plunge on 7-16 (A-shares -16.4%, H-shares -23%) has partially priced in this tail. This report maintains its tail-risk characterization because: ① The investigating body is the prosecutors' office (criminal investigation) rather than an administrative regulator, with a heavier consequence spectrum; ② The core risk is not the fine magnitude (estimated surcharge cap of ~RMB 330 million, no existential risk vs net cash of RMB 17.88 billion), but that being found to have colluded would itself give Samsung/hynix bargaining leverage for price cuts and dual-sourcing (shifting to co-defendants Renesas/Rambus), directly hitting the pricing-power foundation behind the 69.3% interconnect gross margin; ③ The US DOJ's investigation of the same case was an information dimension not fully visible during July's market decline. If Korean customers cut prices 10% during the investigation, interconnect gross margin would fall ~3.4pct, with annualized gross profit loss of ~RMB 620 million (~23% of annualized non-GAAP net profit).
Key evidence
An arithmetic fact to frankly acknowledge: under this report's own scenario distribution, the probability-weighted expected value is below the current price and the Korean investigation tail skews downside — strictly by odds, the current price falls in the "reasonable to slightly expensive" zone. The basis for maintaining judgment at fair rather than overvalued: the current price deviates 8.4% from the base midpoint, within the ±15% band; the company is hitting an AI-driven structural demand inflection (see E7); growth options accounting for ~85% of the current price is itself not evidence of overvaluation; and the growth-quality gate passes — ROIC of ~18% (2026H1 annualized NOPAT estimate) far exceeds a 9% WACC, new product revenue +80.7%, and gross margin on a sustained uptrend. In other words: this is not "absurdly expensive," but rather "a good price hasn't appeared yet." The sell-side street price anchor (RMB 363–387) is shown for reference but not adopted — if the market persistently prices on the street anchor, this report will be systematically conservative; if consensus is revised down, the 45x anchor itself would shift lower — this is two-way risk.
| Metric (RMB 100M) | FY2023 | FY2024 | FY2025 | 2026H1 |
|---|---|---|---|---|
| Revenue | 22.86 | 36.39 | 54.56 | 33.35 (+26.7%) |
| Net profit attributable to shareholders | 4.51 | 14.12 | 22.36 | 19.97 (+72.3%) |
| Non-GAAP net profit | — | 12.48 | 20.22 | 13.22 (+21.2%) |
| Gross margin | — | 58.1% | 62.2% | 65.3% (+4.87pp) |
| Net margin (attributable) | 19.7% | 38.8% | 41.0% | 59.9% (incl. one-off gains) |
| Operating cash flow | 7.31 | 16.91 | 20.22 | 13.28 (+25.4%) |
| Free cash flow | — | — | 17.56 | 10.73 |
| Cash + cash-like assets | — | — | — | 180.27 (as of 2026-06-30) |
| Interest-bearing debt | — | — | — | 1.42 (as of 2026-06-30) |
| Debt-to-asset ratio | — | — | 4.2% | 7.5% |
| Net cash | — | — | ~167 | ~178.8 (as of 2026-06-30) |
Reasons for metric changes (items with YoY change ≥±20%, company's explanation): ① Investment income and fair-value change gains of RMB 682 million (+5,939%): gains of RMB 456 million recognized on the sale of XConn equity and the Marvell shares received as consideration — one-off; ② Cash +78.2%: receipt of H-share listing proceeds (listed 2026-02-09, net proceeds ~RMB 7.05 billion); ③ Accounts receivable +71.7% (revenue +26.7%): company explained "mainly due to growth in sales revenue this period," without addressing the scissors gap vs revenue growth; ④ FX losses of RMB 174 million (vs RMB 7 million in prior-year period): RMB appreciation against USD, losses on foreign-currency assets from H-share proceeds; ⑤ Other income (mainly government grants) -86.9%: unexplained by the company; ⑥ Inventory write-downs shifted from a reversal of RMB 31 million last period to a provision of RMB 21 million this period: unexplained by the company.
2026H1 revenue was RMB 3.335 billion (+26.7%), with Q2 alone at RMB 1.875 billion (+32.8%, +28.3% QoQ) — revenue accelerating quarter by quarter, validating volume-and-price gains from AI server demand and DDR5 sub-generation upgrades. Attributable net profit of RMB 1.997 billion (+72.3%) fell within the pre-announced range (RMB 1.9–2.1 billion), and non-GAAP net profit of RMB 1.322 billion (+21.2%) at the midpoint of the guided range (RMB 1.25–1.45 billion); Q2 non-GAAP profit was ~RMB 719 million, +19% QoQ vs Q1 (RMB 604 million). By structure: interconnect revenue of RMB 3.111 billion (+26.4%) with 69.3% gross margin; Jintide revenue of RMB 220 million (+31.2%) but gross margin only ~9.7%, with the Q2 Jintide ramp pulling overall gross margin down to ~61.8%. New product revenue of RMB 538 million (+80.7%) but flat sequentially in Q2 (see C2). Beat or miss: the company gave no earnings guidance, so there is no definitive market anchor to compare against; on consensus progress, H1 attributable net profit of RMB 1.997 billion already exceeds the run-rate share of FY2026E attributable net profit (~RMB 3.55 billion), with revenue in line with or slightly above sell-side expectations — but the cliff-like deceleration in non-GAAP growth (+21.2%) vs full-year 2025 (+62%) is the focal point of market disagreement. Interim dividend of RMB 2 per 10 shares (RMB 242 million total, 12.1% of H1 attributable net profit).
Business model snapshot: Fabless, asset-light chip design, with upstream wafer foundry/packaging & testing outsourced (top five suppliers account for 79.39% of procurement), and downstream DRAM OEMs and module makers such as Samsung/SK Hynix/Micron (top five customers account for 77.24% of sales). Revenue is point-in-time chip sales with no recurring subscription component; pricing power comes from DDR5 sub-generation iterations (new sub-generations start at higher prices and decline as volumes ramp, keeping ASP relatively stable) and sole-supply windows for new category launches (MRCD/MDB first generation as sole global supplier; CKD first to mass production globally). It occupies the most favorable midstream position in industry value distribution: strong bargaining power over downstream buyers due to a three-player oligopoly plus high switching costs, with gross profit mainly retained at the design stage (interconnect gross margin of 69.3% vs. far lower levels at DRAM OEMs and module makers).
Cash content of earnings test: OCF/net profit attributable to parent from 2023 to 2026H1 was 1.62→1.20→0.90→0.66, appearing to decline continuously; however, after stripping out one-off gains, OCF/non-recurring-adjusted (adjusted) net profit was approximately 1.00 in 2026H1, and OCF growth of +25.4% YoY matches the adjusted profit growth (+21.2%)—cash generation is healthy, and the ratio decline is a statistical illusion caused by the denominator being inflated by RMB 675 million of non-recurring gains. FCF/adjusted profit was approximately 0.81 in 2026H1 (FCF of RMB 1.073 billion); CapEx of RMB 255 million was mainly for the Lingang R&D center construction (cumulative investment at 88.9% of budget), not a capacity black hole; CapEx/depreciation of about 3.2x reflects the R&D infrastructure investment phase and will fall back upon project completion. Recurring earnings test: The 34% gap between 2026H1 adjusted net profit of RMB 1.322 billion and attributable net profit of RMB 1.997 billion far exceeds the ±15% warning line—RMB 675 million came from one-off items (XConn/Marvell disposals of RMB 456 million + changes in fair value of financial assets); the core earnings trend is adjusted profit +21.2%, not attributable profit +72.3%. Company's self-reported Non-GAAP measure is loose: excluding share-based compensation, attributable profit was RMB 2.180 billion (H1 SBC of RMB 191 million), treating recurring annual incentive costs as nonexistent; FY2025 SBC was 19.3% of attributable net profit—using this measure for valuation would systematically overstate value.
Return on capital: ROIC approximately 18% (annualized NOPAT basis, 2026H1), far above WACC of 9% and the SW Digital Chip Design sector median ROE of 5.3%—a genuine moat signal for an asset-light, high-margin business. Red flags: ① Extremely high customer concentration among a buyer oligopoly (Samsung/Hynix/Micron hold 90%+ of global DRAM), top five customers at 77.24%; ② receivables from the largest customer remained high at 48.7%; ③ decline in government subsidies (other income -86.9%) unexplained; ④ Hengqin subsidiary persistently loss-making (-RMB 211 million in 2025, insolvent), requiring related-party capital injections.
Consistency between words and deeds: Pragmatic, mostly delivering on commitments. ① The 2026-07-17 profit pre-announcement guided attributable profit of RMB 1.9–2.1 billion / adjusted profit of RMB 1.25–1.45 billion → actual figures of RMB 1.997/1.322 billion, both within range (adjusted at midpoint); ② the 2025 annual report committed to H-share listing in early 2026 → listed on 2026-02-09 with net proceeds of approximately RMB 7.05 billion, delivered; ③ the MRCD/MDB "ramp over the next two to three years" messaging has been consistent from June to August 2026 and in the interim report, no exaggeration observed; ④ PCIe 7.0 Retimer/Switch "engineering sample tape-out within the year" was still in progress as of H1, partially delivered. The narrow guidance range and mid-range landing suggest high guidance credibility.
Shareholder friendliness: Favors returns. FY2025 dividends + buybacks totaled RMB 1.119 billion, 50.07% of attributable net profit; cumulative dividends of RMB 2.839 billion since the 2019 listing; the second 2025 buyback of RMB 220 million has been completed and cancelled; the 2026 new buyback plan of RMB 300–600 million has deployed approximately RMB 170–190 million as of 8-28 (about 55–60% of the lower bound); the chairman proposed buybacks during share price drawdowns, and market cap has been included in executive performance assessments for five consecutive years. Flaws: the February 2026 H-share issuance of 75.77 million shares diluted ~6.2% (but net proceeds of RMB 7.05 billion strengthened net cash); financial shareholders cumulatively net-sold about 3% of total shares over the past 12 months (Shanghai Rongying/Zhuhai Rongying sold 1.47% combined in 2026-01; China Electronics Investment & Holdings sold 0.86% in 2025-10), a gradual supply overhang.
Risk signals: No actual controller (neutral governance); related-party transactions consist of a RMB 250 million capital increase to controlled subsidiary Hengqin (at the same price as third-party Yunfeng, RMB 22.50 per registered capital—market-based pricing) + a USD 70 million guarantee facility (guarantee balance of 0 at period end); no insider selling by directors/supervisors/senior management in the past 12 months, plus a 6-month no-sale commitment.
| Segment | 2026H1 Revenue | Share | Gross Margin | YoY | Business Logic |
|---|---|---|---|---|---|
| Interconnect chips (memory interface/companion, PCIe Retimer, CXL MXC, clock) | RMB 3.111 bn | 93.3% | 69.3% | +26.4% | JEDEC standard lead author; DDR5 sub-generation iteration + first-mover positioning in new categories |
| Jintide product line (CPU and trusted computing acceleration chips) | RMB 220 mn | 6.6% | ~9.7% | +31.2% | Targets China's domestic server market; low margin, small scale |
Profit-driving segment: Interconnect contributes ~93.3% of revenue × 69.3% gross margin, accounting for over 99% of gross profit—although Jintide's Q2 volume ramp dragged the blended gross margin down ~8pct, its profit contribution is negligible. Gross margin structure divergence: Interconnect at 69.3% vs. Jintide at ~9.7%, a gap of nearly 60pct—the former is a pricing-power business built on a three-player oligopoly plus standard-setting authority, while the latter is essentially a low-value-added localization/integration business; the two have completely different business models. Each 1pct increase in Jintide's revenue share lowers the blended gross margin by ~0.6pct—noise that must be stripped out when interpreting quarterly gross margin swings. Regional structure: overseas revenue at 69.7% with ~70.6% gross margin; domestic at 30.3% with ~53.3% gross margin.
Accounting red flags: ① One-off investment gains inflating profit (severity: high)—non-recurring gains of RMB 675 million were 33.8% of attributable net profit, including RMB 456 million from XConn/Marvell disposals; attributable growth (+72.3%) far outpaced adjusted growth (+21.2%); earnings quality must be assessed on the adjusted basis; ② receivables growth significantly outpacing revenue (med)—receivables of RMB 975 million (+71.7%) vs. revenue +26.7%, with bad debt provisioning of only 0.50%; the company attributes this to revenue growth, but the Q2 concentration + largest customer at 48.7% warrant monitoring of collections; ③ Non-GAAP add-back of recurring SBC expense (med)—H1 attributable profit of RMB 2.180 billion after exclusion; SBC is a persistent cost; aggressive measure; ④ inventory write-down direction reversal (low)—prior-period reversal of RMB 31 million → current-period provision of RMB 21 million, unexplained by management; period-end write-down provision rose to RMB 208 million; ⑤ sharp drop in government subsidies unexplained (low)—other income of RMB 8 million vs. RMB 61 million in the prior period.
Cross-period consistency: ① OCF/attributable net profit declining from 1.62→1.20→0.90→0.66—the company only stated "operating cash flow remains steady" without explaining the declining ratio (about 1.0 on the adjusted basis; actually a denominator illusion, but the company indeed did not proactively clarify); ② largest customer's share of receivables jumped from 31.69%→48.62%→48.70% and stayed high—the company did not explain the jump, stating only on the investor interaction platform "top-tier customer, good historical payment record, no bad debts"; ③ SBC expense jumped from RMB 50 million→431 million→191 million (annualized ~RMB 380 million) and stayed high—consistent with H-share incentive plan amortization; explanation consistent; ④ R&D expense ratio declining from 29.83%→20.98%→16.77%→13.58%—absolute R&D spending grew each year (H1 +26.9%); the ratio decline reflects faster revenue growth; explanation consistent. Overall: no signs of aggressive revenue recognition or profit manipulation; the main issue is optimistic presentation of metrics (attributable/Non-GAAP), and investors should switch to the adjusted basis themselves.
Current market data: Share price RMB 204.95 (close, 2026-08-31), market cap approximately RMB 250.1 billion (RMB 204.95 × 1.2205 billion shares); PE (TTM attributable) 81.4x (57th percentile over 5 years), PE (TTM adjusted) 111.0x, PB 12.1x (86th percentile over 5 years), PS (TTM) ~44x. Earnings are not representative (TTM attributable includes RMB 675 million of one-off gains; the company is in an AI-driven growth phase), so the PE percentile is for reference only, not a headline cheap/rich signal. Forward basis: 70.5x FY2026E consensus EPS, 51.2x FY2027E, PEG ~1.36 (51.2 ÷ 37.6%).
Peer comparison:
| Company | PE (TTM) | Revenue Growth | Gross Margin | ROE | Key Differentiator |
|---|---|---|---|---|---|
| Montage Technology | 81.4x | 2026H1 +26.7% | 65.3% | FY2025 18.4% | Memory interface core + new connectivity products; highest earnings quality |
| Rambus (RMBS) | 38.8x | FY2025 +27.1% | 79.8% incl. licensing | 18.5% | Peer among the big three, with high-margin patent licensing |
| Astera Labs (ALAB) | 132.8x | FY2025 +115% | 75.7% | 18.8% | Pure-play AI interconnect leader; highest growth and multiple |
| SW Digital Chip Design median | 53.3x | +21.9% | — | 5.3% | Montage's ROE at the 87th percentile of the sector |
Market-implied expectations: The current price implies two combinations—51.2x exit multiple on consensus FY2027E EPS of 4.0, or a 45x exit multiple implying 2027E EPS of 4.55 (~14% above consensus). The reality: TTM adjusted EPS of RMB 1.85; this report's own FY2027 attributable estimate of RMB 4.4–4.8 billion (EPS 3.6–3.9, 3–10% below consensus, using a conservative adjusted basis). The current price requires the company to deliver at the top of consensus earnings in 2027 with no multiple compression at 45x—"reachable but not comfortable." Demand math, tested both ways: AI server shipments +31% in 2026 (TrendForce upgrade) × ~10x MRDIMM per-module value × CKD 0→1 × Montage's first-mover share across all categories, supporting a 2026–2028 revenue CAGR of ~26% (RMB 7.3→11.7 billion)—the growth implied by the current price is backed by a real demand chain, not narrative froth; but it leaves no room for upside surprises.
Three-layer value (EPV): Asset value RMB 17.6/share (floor); EPV with zero growth RMB 31.3/share (normalized EPS of RMB 1.50 ÷ WACC of 9% + net cash of RMB 14.65/share; normalized base = TTM adjusted profit of RMB 2.253 billion less excess cash interest of ~RMB 427 million = RMB 1.826 billion ÷ 1.2205 billion shares); growth option = current price 204.95 − EPV 31.3 ≈ RMB 173.7/share, ~85% of the current price. The price is almost entirely supported by the growth option—for a structural inflection-name this is normal rather than evidence of overvaluation, but it means valuation is highly sensitive to the 2026–2028 new product ramp curve: EPV is the downside floor (an extreme reference at roughly -85%); the real swing factor lies in ramp scenarios.
Three scenarios and odds:
| Scenario | Fair Range (RMB) | Probability | vs. Current | Swing Factor |
|---|---|---|---|---|
| Bear | 100–115 | 25% | -51% to -44% | AI capex pullback in 2027 + MRDIMM platform delay + adverse outcome in Korea investigation (lawsuit/fine + customer dual-sourcing) → 2027E EPS falls to 2.8–3.0, exit multiple compressed to 35–38x (Rambus 38.8x lower bound + sector bear-market discount) |
| Base | 180–198 | 45% | -12% to -3% | MRDIMM/CKD/PCIe 6.x delivered per management's "two-to-three-year ramp" + AI servers +31% → FY2027E EPS 4.0–4.4 × 45x |
| Bull | 235–264 | 30% | +15% to +29% | MRDIMM ramps early in 2027 + PCIe 6.x/7.0 volumes catching up to Astera + CXL commercializes at scale → FY2027E EPS 4.7–4.8 × 50–55x (half of Astera's 132.8x growth premium) |
Exit multiple anchoring rationale: The base 45x anchors to Rambus's current TTM 38.8x (actual calculation as of 2026-08-28, already compressed from ~44x after this round of AI correction) + Montage's 15–25% share/category leadership premium over Rambus (historical range); benchmarked against the SW Digital Chip Design median of 53.3x. Discounting cross-check: 2026–2028 revenue CAGR of 26% × adjusted net margin of 40% → 2028 adjusted EPS of ~3.83 × 45x = RMB 172, discounted 2 years at 9% ≈ RMB 145—this conservative basis suggests the upper bound of the base range requires growth duration support; the primary basis (2027 exit-year earnings × 45x, no additional discounting) is consistent with the previous report. Bear case benchmarked against the most pessimistic published market positions: lowest sell-side target price of RMB 185, no named institution has published a numeric bearish forecast, and the market's bear side (US law firm civil claims investigation) has given no numeric target—the bear case of RMB 100–115 corresponds to a compounded worst case of "lawsuit + customer dual-sourcing + AI capex pullback," below all published forecasts, i.e., a self-imposed stress test. The current price sits between the upper bound of the base range and the lower bound of the bull scenario: downside to the bear-case midpoint is about -48%, upside to the bull-case midpoint about +22%—the odds are asymmetrically skewed to the downside.
Conclusion: Fair to slightly expensive (fair). Target price range RMB 180–198 (base scenario); current price of RMB 204.95 is 3.4% above the upper bound and 8.4% above the midpoint, with a safety margin of -12%. Separate quality from price: ROIC of 18%, net cash of RMB 17.88 billion, first-mover positioning across all product categories—first-tier quality, paired with a price that has already priced in the base scenario. Actionable implication: existing holders can stay invested awaiting bull-case catalysts (9-8 earnings briefing, Q3 report, outcome of the Korea investigation); new capital should wait for a pullback toward RMB 180 or clarity on the investigation; do not chase.
Market size: The segment where Montage truly competes is "memory interface and interconnect chips" — including DDR5 RCD/DB, MRCD/MDB chipsets for MRDIMM, client clock drivers (CKD), PCIe Retimers, CXL memory expansion controllers (MXC) and companion chips. Segment sizes: ① Memory interface chips (RCD/DB and module companion chips) were ~US$1.168 billion globally in 2024 (per Korean media/Sina Tech citing industry data); another estimate (QYResearch, re-cited by Montage in 2026-06) puts it at ~US$878 million in 2026, reaching US$1.962 billion by 2032, a 2026–2032 CAGR of ~12.4% — the discrepancy between the two stems from whether module companion chips are included; the latter is flagged as pending verification; ② PCIe Retimer + Switch: QYResearch forecasts US$7.761 billion by 2030, 2025–2030 CAGR of 20.1% (cited in Montage's official IR, primary source); ③ MRCD/MDB: broker estimates of ~US$270 million → US$590 million over the next three years (cited by Cailian Press, year basis pending verification); ④ CKD: ramping from zero with AI PCs/DDR5≥6400MT/s; standalone market size not obtained. Historical proxy for industry growth: Montage's interconnect revenue +53.3% in 2024, +53.4% in 2025; Astera Labs revenue +242%/+115% in 2024/2025 respectively.
Quantified chain of the demand inflection (structural self-check): This demand is an exogenous platform shift rather than organic growth, and every link in the chain has verifiable numbers — driving variables: AI server shipments +24.1% in 2025, with 2026 growth revised up from +28% to ~+31% (TrendForce, 2026-08-03); AI servers account for ~70% of server market value; AI is expected to consume 66% of DRAM capacity in 2026 (Cailian Press citing institutional forecasts); step-change in unit content: PCIe Retimers rising from 2–4 units per general-purpose server → 8–16 units in 8-GPU AI servers (24 units in some domestic designs, Montage interim report citing industry data); MRDIMM's "1 MRCD + 10 MDB" raises interface chip value per module from ~US$7 (single RCD on RDIMM) to over US$70 (~10x, industry estimates); CKD is a new 0→1 category for PC DDR5≥6400MT/s; AI server DRAM capacity is 4–5x that of general-purpose servers, directly amplifying total RCD/MRCD usage; penetration ramp: server DDR5 penetration already above 85% in 2025, PCs at ~70–80%; MRDIMM ramps with new CPU platforms launching in 2025H2–2026, CKD enters volume shipments in 2026Q1, PCIe 6.0 platforms approaching in 2026–2027, CXL 3.x landing with CPU platforms from 2026; company share: 36.8% in memory interface, global No.1 and rising; sole global supplier of Gen-1 MRCD/MDB, first to mass-produce Gen-2 (12800MT/s); first globally to mass-produce CKD (sole-supply window); first globally to be listed on the CXL compliance list with MXC and first to trial-produce 3.2; one of the main PCIe Retimer suppliers. Conclusion: this is a structural rightward shift of the demand curve, not cyclical fluctuation — valuation should anchor on a growth framework (forward PE/PEG/ramp models), with PE percentile and mid-cycle normalization serving only as a downside floor reference.
Value chain and value distribution: Upstream is foundry and packaging/testing (Fabless procurement; small die area, limited bargaining power; core IPs such as SerDes/low-jitter clocks are self-developed — 32GT/s in mass production, 64GT/s in development, 128GT/s in the pipeline); midstream is memory interface/interconnect chip designers (Montage, Renesas, Rambus; on the PCIe side also Astera Labs and Parade); downstream is DRAM makers such as Samsung/SK Hynix/Micron and module makers such as Kingston, ultimately installed in server OEM/ODM and cloud providers. Gross profit is retained mainly at the midstream design layer — Montage's interconnect gross margin of 69.3% is far higher than downstream DRAM makers and module houses. Montage has strong bargaining power downstream (oligopoly + high certification switching costs), but is under regulatory constraint from the Korean antitrust investigation — a regulatory backlash against high pricing power.
Supply-demand and competitive landscape: On the demand side, three drivers (AI server volume, DDR5 generation-by-generation price increases, new 0→1 categories); on the supply side, only 3 global suppliers of memory interface main chips and no new entrants for 20+ years; during the 2025–2026 memory supercycle, DRAM capacity tilts toward HBM and server DDR5 is in shortage (SK Hynix stated in 2026-04 that "the memory market has turned into a seller's market, with only ~4 weeks of inventory"); the industry is tight, leaning toward shortage. Concentration: memory interface CR3 = 93.4% (2024), Montage No.1 at 36.8%; the PCIe Retimer market is more fragmented, with Astera Labs as leader (FY2025 revenue US$852.5 million, +115%) and Montage the main challenger. Entry barriers: ① high-speed low-jitter clock/SerDes analog design requires 20 years of accumulation; ② pre-validation with CPU platforms (Intel/AMD/ARM) plus certification cycles to enter DRAM makers' qualified supplier lists; ③ JEDEC standards influence (Montage leads the DDR6 interface standard); ④ first-mover positioning in new categories. Price-war risk is low but present — the Korean investigation directly targets "bid collusion" among the big three; if substantiated, pricing power would be compressed. Substitution threat is low: interface chips are indispensable as memory generations evolve; CXL/Memory Fabric architecture shifts actually favor MXC.
Cyclicality and regulation: The industry is in a "growth phase overlaid with the upswing of a memory supercycle," not a typical cyclical profile (Montage 2024/2025 revenue +59%/+50%). Leading indicators: AI server shipments and CSP capex (TrendForce quarterly upward revisions), DDR5 generation-switch cadence, MRDIMM attach rate, CKD shipments, DRAM contract prices, mass-production timing of PCIe 6.0 server CPU platforms. Three regulatory threads: ① Korean criminal antitrust investigation (see C4) — compliance risk against the oligopoly's high pricing power, neutral-to-negative; ② US export controls — main impact falls on the already-marginalized Jintide platform; memory interface chips are not on the US control list, but as a Chinese company deeply embedded in Samsung/SK Hynix supply chains, Montage faces two-way geopolitical exposure; ③ domestic Big Fund and STAR Market support for interconnect chip localization, neutral-to-positive.
Peer comparison:
| Company | Revenue scale | Revenue growth | Gross margin | ROE | Rank/differences vs Montage |
|---|---|---|---|---|---|
| Montage Technology | 2025: RMB 5.456 billion (interconnect RMB 5.139 billion) | 2025 +49.9%; 2026H1 +26.7% | 65.3% (interconnect 69.3%) | 18.4% | Global No.1 in memory interface (36.8%) |
| Rambus | FY2025 US$707.6 million (~RMB 5.06 billion) | +27.1% | 79.8% incl. licensing | 18.5% | One of the big three; includes IP/patent licensing; pure product revenue smaller than Montage's interconnect |
| Astera Labs | FY2025 US$852.5 million (~RMB 6.10 billion) | +115% (2024 +242%) | 75.7% | 18.8% | PCIe Retimer/Switch leader; no memory interface base; high elasticity, high volatility |
| Renesas Electronics | CY2025 ¥1.32 trillion (~RMB 66.0 billion) | -2.0% | 52–56% | Negative (net loss ¥51.8 billion) | Memory interface is a marginal part of its automotive/industrial business, low investment priority |
| Giantec Semiconductor | 2025: RMB 1.221 billion | +18.8% | Not obtained | Not obtained (net profit attributable RMB 364 million) | Major DDR5 SPD EEPROM supplier; Montage's complementary partner, not a competitor |
Positioning within the industry: The absolute leader. Share trend rising: 36.8% memory interconnect share in 2024, global No.1 (Frost & Sullivan basis, cited in the company's annual report), with first-mover positioning in every incremental category (MRCD/MDB, CKD, CXL MXC all global firsts; PCIe Retimer among the main suppliers). Moat sources: 20+ years of high-speed clock/SerDes analog design accumulation, JEDEC standards influence, deep pre-validation bindings with CPU platforms and DRAM makers, and 60–70%+ gross margin and ~40% net margin profitability quality on an asset-light Fabless model. The company is transitioning from a "DDR5 generational-upgrade cyclical growth stock" to an "AI compute/interconnect chip growth stock," aligning with the growth logic of the AI interconnect track where Astera Labs plays; key variables are the outcome of the Korean antitrust case and the ramp pace of new products.
Overall assessment: Maintain Neutral, confidence 0.55, time horizon 12 months. Montage Technology is a scarce A-share play on "global oligopoly + AI structural inflection": first-class fundamentals (2026H1 adjusted net profit +21.2%, interconnect gross margin 69.3%, ROIC ~18%, net cash RMB 17.88 billion), a genuine demand inflection (+31% AI servers × step-change in unit content × first-mover positioning across all categories), but the current price of RMB 204.95 has largely priced in the base case (probability-weighted expected value RMB 186.8, 8.9% below the current price), and the Korean investigation plus US civil claims form a downside-skewed tail. Strategy: don't chase, don't short — quality is high but positioning is crowded (17 Buy + 6 Overweight, 0 Sell); shorting a quality leader offers poor odds. New capital should wait for two types of entry signals: ① pullback to around RMB 180, the lower bound of the base-case range (margin of safety turns positive); ② clarity on the Korean investigation via settlement/dismissal (removing the tail discount), or Q3 results confirming adjusted net profit growth ≥20% with sequential re-acceleration of new products.
Risk disclosures: Escalation of the Korean investigation to prosecution/fines triggering customer dual-sourcing (thesis breaker); 2026 full-year adjusted growth below 15%, or H2 headline net profit turning negative due to a high base, triggering selling unrelated to fundamentals; interconnect gross margin below 65% for two consecutive quarters; delays to 2028 of the next-generation CPU platforms on which MRDIMM/PCIe 6.x depend; RMB appreciation widening FX losses (a further 5% rise would erode ~11–15% of annualized adjusted net profit); continued selling by financial shareholders and gradual supply from H-share cornerstone unlock.
Key citation list: The conclusions of this report rest primarily on the following materials — 2026 Interim Report (8-29; adjusted profit/margin/new products/investigation/buyback core data), 2025 Annual Report (36.8% share/customer concentration/SBC basis), 2026H1 positive earnings pre-announcement (guidance verification), Korean investigation disclosure announcement (2026-040), PCI-SIG certification and CXL 3.2 trial-production press releases, TUSHARE consensus cache, TrendForce AI server shipment data, and SSE e-interaction Q&A excerpts (management commentary).